Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Qianhui Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6035-1687; OpenAlex author ID A5101862046. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 2 papers

Papers 5

  1. N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-022-02614-x↗
  2. Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fgene.2022.866340↗
  3. Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinom… Co-author DOI 10.1038/s41420-021-00663-1↗
  4. Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12935-021-02289-w↗
  5. Identification of Robust Immune‐Associated lncRNAs Signature for Immune Checkpoint Blockade and Prognosis in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-113463/v1↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wen Huang · 4 shared papers, 2020–2022 · strength 0.80
  2. Yuxin Wang · 2 shared papers, 2020–2022 · strength 0.41
  3. Yutian Ji · 1 shared paper, 2022 · strength 0.22
  4. Hao Xu · 1 shared paper, 2022 · strength 0.20
  5. Rujun Xu · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.